Neuroprotection against excitotoxic brain injury in mice after ovarian steroid depletion

Brain Research

Volumn 1265, Issue , 2009, Pages 37-46

  Schauwecker, P Elyse ^a   Wood, Ruth I ^a   Lorenzana, Ariana ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

4 Vinylcyclohexene diepoxide; Estrogen; Neuroprotection; Ovariectomy; Progesterone

Indexed keywords

4 VINYLCYCLOHEXENE DIEPOXIDE; EPOXIDE; ESTRADIOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; DISEASE DURATION; DISEASE MODEL; DISEASE PREDISPOSITION; EPILEPTIC STATE; ESTROGEN THERAPY; EXCITOTOXICITY; FEMALE; HIPPOCAMPUS; HORMONE DEFICIENCY; LATENT PERIOD; MOLECULAR INTERACTION; MOUSE; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; OVARIECTOMY; OVARY FOLLICLE; OVARY INSUFFICIENCY; PRIORITY JOURNAL; SEIZURE; TEMPORAL LOBE EPILEPSY;

ADMINISTRATION, CUTANEOUS; ANIMALS; BRAIN; CARCINOGENS; CELL DEATH; CYCLOHEXENES; DISEASE MODELS, ANIMAL; ESTROGENS; EXCITATORY AMINO ACID AGONISTS; FEMALE; HIPPOCAMPUS; HISTOLOGY; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; KAINIC ACID; MICE; MICE, INBRED STRAINS; NEURONS; NEUROPROTECTIVE AGENTS; OVARIAN FOLLICLE; OVARIECTOMY; OVARY; SEIZURES; VINYL COMPOUNDS;

MUS;

EID: 62949203854     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.02.023     Document Type: Article

References (75)

1. Aguado L.I., and Ojeda S.R. Ovarian adrenergic nerves play a role in maintaining preovulatory steroid secretion. Endocrinology 114 (1984) 1944-1946
2. Azcoitia I., Sierra A., and Garcia-Segura L.M. Estradiol prevents kainic acid-induced neuronal loss in the rat dentate gyrus. NeuroReport 9 (1999) 3075-3079
3. Azcoitia I., Sierra A., and Garcia-Segura L.M. Neuroprotective effects of estradiol in the adult rat hippocampus: interaction with insulin-like growth factor-I signaling. J. Neurosci. Res. 58 (1999) 815-822
4. Azcoitia I., Garcia-Ovejero D., Chowen J.A., and Garcia-Segura L.M. Astroglia play a key role in the neuroprotective actions of estrogen. Prog. Brain Res. 132 (2001) 469-478
5. Bäckström T., and Rosciszewska D. Effects of hormones on seizure expression. In: Engel Jr. J., and Pedley T.A. (Eds). Epilepsy: A Comprehensive Textbook (1997), Lippincott Raven, Philadelphia 2003-2012
6. Bedard P.J., Langlelier P., and Vileneuve A. Estrogens and the extrapyramidal system. Lancet 2 (1977) 1367-1368
7. Bauer J. Interactions between hormones and epilepsy in female patients. Epilepsia 42 Suppl 3 (2001) 20-22
8. Ben-Ari Y. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 14 (1985) 375-403
9. Ben-Ari Y., Tremblay E., Berger M., and Nitecka L. Kainic acid seizure syndrome and binding sites in developing rats. Brain Res. 316 (1984) 284-288
10. Borman S.M., VanDePol B.J., Kao S., Thompson K.E., Sipes I.G., and Hoyer P.B. A single dose of the ovotoxicant 4-vinylcyclohexene diepoxide is protective in rat primary ovarian follicles. Toxicol. Appl. Pharmacol. 158 (1999) 244-252
11. Brinton R.D. Impact of estrogen therapy on Alzheimer's disease: a fork in the road?. CNS Drugs 18 (2004) 405-422
12. Browne T.R., and Holmes G.L. Epilepsy. New Engl. J. Med. 344 (2001) 1145-1151
13. Buterbaugh G.G. Estradiol replacement facilitates the acquisition of seizures kindled from the anterior neocortex in female rats. Epilepsy Res. 4 (1989) 207-215
14. Currie L.J., Harrison M.B., Trugman J.M., Bennett J.P., and Wooten G.F. Postmenopausal estrogen use affects risk for Parkinson disease. Arch. Neurol. 61 (2004) 886-888
15. Cyr M., Calon F., Morissette M., and Di Paolo T. Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease. J. Psychiatry Neurosci. 27 (2002) 12-27
16. Devine P.J., Sipes I.G., and Hoyer P.B. Initiation of delayed ovotoxicity by in vitro and in vivo exposures of rat ovaries to 4-vinylcyclohexene diepoxide. Reprod. Toxicol. 19 (2004) 71-77
17. Edwards H.E., Burnham W.M., Mendonca A., Bowlby D.A., and MacLusky N.J. Steroid hormones affect limbic afterdischarge thresholds and kindling rates in adult female rats. Brain Res. 838 (1999) 136-150
18. Franklin K.B.J., and Paxinos G. The Mouse Brain in Stereotaxic Coordinates (1997), Academic Press, New York
19. Frye C.A. The neurosteroid 3α,5α-THP has antiseizure and possible neuroprotective effects in an animal model of epilepsy. Brain Res. 696 (1995) 113-120
20. Frye C.A., and Bayon L.E. Cyclic withdrawal from endogenous and exogenous progesterone increases kainic acid and perforant pathway induced seizures. Pharmacol. Biochem. Behav. 62 (1999) 315-321
21. Fujikawa D.G. Neuroprotective effect of ketamine administered after status epilepticus onset. Epilepsia 36 (1995) 186-195
22. Fujikawa D.G. The temporal evolution of neuronal damage from pilocarpine-induced status epilepticus. Brain Res. 725 (1996) 11-22
23. Fujikawa D.G., Daniels A.H., and Kim J.S. The competitive NMDA receptor antagonist CGP 40116 protects against status epilepticus-induced neuronal damage. Epilepsy Res. 17 (1994) 207-219
24. Galanoupoulou A.S., Alm E.M., and Velišková J. Estradiol reduces seizure-induced hippocampal injury in ovariectomized female but not in male rats. Neurosci. Lett. 342 (2003) 201-205
25. Gazzaley A.H., Weiland N.G., McEwen B.S., and Morrison J.H. Differential regulation of NMDAR1 mRNA and protein by estradiol in the rat hippocampus. J. Neurosci. 16 (1996) 6830-6838
26. Henderson V.W. Estrogen replacement therapy for the prevention and treatment of Alzheimer's disease. CNS Drugs 8 (1997) 343-351
27. Herzog A.G. Progesterone therapy in women with epilepsy: a 3-year follow-up. Neurology 52 (1999) 1917-1918
28. Herzog A.G., Harden C.L., Liporace J., Pennell P., Schomer D.L., Sperling M., Fowler K., Nikolov B., Shuman S., and Newman M. Frequency of catamenial seizure exacerbation in women with localization-related epilepsy. Ann. Neurol. 56 (2004) 431-434
29. Hoffman G.E., Moore N., Fiskum G., and Murphy A.Z. Ovarian steroid modulation of seizure severity and hippocampal cell death after kainic acid treatment. Exp. Neurol. 182 (2003) 124-134
30. Hom A.C., and Buterbaugh G.G. Estrogen alters the acquisition of seizures kindled by repeated amygdala stimulation or pentylenetetrazol administration in ovariectomized female rats. Epilepsia 27 (1985) 103-108
31. Hu X., Roberts J.R., Apopa P.L., Kan Y.W., and Ma Q. Accelerated ovarian failure induced by 4-vinylcyclohexene diepoxide in Nrf2 null mice. Mol. Cell. Biol. 26 (2006) 940-954
32. Jacob D.A., Temple J.L., Patisaul H.B., Young L.J., and Rissman E.F. Coumestrol antagonizes neuroendocrine actions of estrogen via the estrogen receptor α. Exp. Biol. Med. 226 (2001) 301-306
33. Jacobs M.P., Fischbach G.D., Davis M.R., Dichter M.A., Dingledine R., Lowenstein D.H., Morrell M.J., Noebels J.L., Rogawski M.A., Spencer S.S., and Theodore W.H. Future directions for epilepsy research. Neurology 57 (2001) 1536-1542
34. Kalkbrenner K.A., and Standley C.A. Estrogen modulation of NMDA-induced seizures in ovariectomized and non-ovariectomized rats. Brain Res. 964 (2003) 244-249
35. Kao S.-W., Sipes I.G., and Hoyer P.B. Early effects of ovotoxicity induced by 4-vinylcyclohexene diepoxide in rats and mice. Reprod. Toxicol. 13 (1999) 67-75
36. Landgren S., Backstrom T., and Kalistratov G. The effect of progesterone on the spontaneous interictal spike evoked by the application of penicillin to the cat's cerebral cortex. J. Neurol. Sci. 36 (1978) 119-133
37. MacLusky N.J., Bowlby D.A., Brown T.J., Peterson R.E., and Hochberg R.B. Sex and the developing brain: suppression of neuronal estrogen sensitivity by developmental androgen exposure. Neurochem. Res. 22 (1997) 1395-1414
38. Maguire J.L., Stell B.M., Rafizaheh M., and Mody I. Ovarian cycle-linked changes in GABA(A) receptors mediating tonic inhibition alter seizure susceptibility and anxiety. Nat. Neurosci. 8 (2005) 797-804
39. Mayer L.P., Pearsall N.A., Christian P.J., Devine P.J., Payne C.M., McCuskey M.K., Marion S.L., Sipes I.G., and Hoyer P.B. Long-term effects of ovarian follicular depletion in rats by 4-vinylcyclohexene diepoxide. Reprod. Toxicol. 16 (2002) 775-781
40. McEwen B.S. Gonadal and adrenal steroids regulate neurochemical and structural plasticity of the hippocampus via cellular mechanisms involving NMDA receptors. Cell. Mol. Neurobiol. 16 (1996) 103-116
41. Morrell M.J. Epilepsy in women. Am. Fam. Phys. 66 (2002) 1489-1494
42. Morrison R.S., Wenzel H.J., Kinoshita Y., Robbins C.A., Donehower L.A., and Schwartzkroin P.A. Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death. J. Neurosci. 16 (1996) 1337-1345
43. Murphy D.D., Cole N.B., Greenberger V., and Segal M. Estradiol increases dendritic spine density by reducing GABA neurotransmission in hippocampal neurons. J. Neurosci. 18 (1998) 2550-2559
44. Nadler J.V., and Cuthbertson G.J. Kainic acid neurotoxicity toward hippocampal formation: dependence on specific excitatory pathways. Brain Res. 195 (1980) 47-56
45. Nadler J.V., and Evenson D.A. Use of excitatory amino acids to make axon-sparing lesions of hypothalamus. Methods Enzymol. 103 (1983) 393-400
46. Nadler J.V., Perry B.W., Gentry C., and Cotman C.W. Degeneration of hippocampal CA3 pyramidal cells induced by intraventricular kainic acid. J. Comp. Neurol. 192 (1980) 333-359
47. National Toxicology Program. NTP toxicology and carcinogenesis studies of 4-vinylcyclohexene (CAS No. 100-40-3) in F344/N rats and B6C3F1 mice (gavage studies). Natl. Toxicol. Program Tech. Rep. Ser. 303 (1986) 1-190
48. National Toxicology Program. Toxicology and carcinogenesis studies of 4-vinyl-1-cyclohexene diepoxide (CAS No. 106-87-6) in F344/N rats and B6C3F1 mice (dermal studies). Natl. Toxicol. Program Tech. Rep. Ser. 362 (1989) 1-249
49. Nelson J.F., Felicio L.S., Osterburg H.H., and Finch C.E. Differential contributions of ovarian and extraovarian factors to age-related reductions in plasma estradiol and progesterone during the estrous cycle of C57BL/6J mice. Endocrinology 130 (1992) 805-810
50. Nicoletti F., Speciale C., Sortino M.A., Summa G., Caruso G., Patti F., and Canonico P.L. Comparative effects of estradiol benzoate, the antiestrogen clomiphene citrate, and the progestin medroxyprogesterone acetate on kainic acid-induced seizures in male and female rats. Epilepsia 26 (1985) 252-257
51. Paganini-Hill A. Estrogen replacement therapy and stroke. Prog. Cardiovasc. Dis. 38 (1995) 223-242
52. Pedersen T., and Peters H. Proposal for a classification of oocytes and follicles in the mouse ovary. J. Reprod. Fertil. 17 (1968) 55-557
53. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32 (1972) 281-294
54. Reibel S., Andre V., Chassagnon S., Andre G., Marescaux C., Nehlig A., and Depaulis A. Neuroprotective effects of chronic estradiol benzoate treatment on hippocampal cell loss induced by status epilepticus in the female rat. Neurosci. Lett. 281 (2000) 79-82
55. Santos J.B., and Schauwecker P.E. Protection provided by cyclosporin A against excitotoxic neuronal death is genotype dependent. Epilepsia 44 (2003) 993-1000
56. Scharfman H.E., and MacLusky N.J. The influence of gonadal hormones on neuronal excitability, seizures and epilepsy in the female. Epilepsia 47 (2006) 1423-1440
57. Schauwecker P.E. Seizure-induced neuronal death is associated with induction of c-Jun N-terminal kinase and is dependent on genetic background. Brain Res. 884 (2000) 116-128
58. Schauwecker P.E. Complications associated with genetic background effects in models of experimental epilepsy. Prog. Brain Res. 135 (2002) 139-148
59. Schauwecker P.E. Modulation of cell death by mouse genotype: differential vulnerability to excitatory amino acid-induced lesions. Exp. Neurol. 178 (2002) 219-235
60. Schauwecker P.E., and Steward O. Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targeting approaches. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 4103-4108
61. Schauwecker P.E., Ramirez J.J., and Steward O. Genetic dissection of the signals that induce synaptic reorganization. Exp. Neurol. 161 (2000) 139-152
62. Schauwecker P.E., Williams R.W., and Santos J.B. Genetic control of sensitivity to hippocampal cell death induced by kainic acid: a quantitative trait loci analysis. J. Comp. Neurol. 477 (2004) 96-107
63. Schmued L.C., Stowers C.C., Scallete A.C., and Xu L. Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons. Brain Res. 1035 (2005) 24-31
64. Sidman R.L., Angevine J.B., Taber, and Pierce E. Atlas of the Mouse Brain and Spinal Cord (1971), Harvard University Press, Cambridge
65. Smith B.J., Mattison D.R., and Sipes I.G. The role of epoxidation in 4-vinylcyclohexene-induced ovarian toxicity. Toxicol. Appl. Pharmacol. 105 (1990) 372-381
66. Sperk G. Kainic acid seizures in the rat. Prog. Neurobiol. 42 (1994) 1-32
67. Sperk G.H., Lassmann H., Baran H., Kish S.J., Seitelberger F., and Hornykiewicz O. Kainic acid induced seizures: neurochemical and histopathological changes. Neuroscience 10 (1983) 1301-1315
68. Spiegel E., and Wycis H. Anticonvulsant effects of steroids. J. Lab. Clin. Med. 30 (1945) 947-953
69. Springer L.N., McAsey M.E., Flaws J.A., Tilly J.L., Sipes I.G., and Hoyer P.B. Involvement of apoptosis in 4-vinylcyclohexene diepoxide-induced ovotoxicity in the rat. Toxicol. Appl. Pharmacol. 139 (1996) 394-401
70. Springer L.N., Tilly J.L., Sipes I.G., and Hoyer P.B. Enhanced expression of bax in small preantral follicles during 4-vinylcyclohexene diepoxide-induced ovotoxicity in the rat. Toxicol. Appl. Pharmacol. 139 (1996) 402-410
71. Thompson K.E., Sipes I.G., Greenstein B.D., and Hoyer P.B. 17beta-estradiol affords protection against 4-vinylcyclohexene diepoxide-induced ovarian follicle loss in Fischer-344 rats. Endocrinology 143 (2002) 1058-1065
72. Velišková J., Velisek L., Galanopoulou A.S., and Sperber E.F. Neuroprotective effects of estrogens on hippocampal cells in adult female rats after status epilepticus. Epilepsia 41 (2000) S30-S35
73. Woolley C.S. Effects of estrogen in the CNS. Curr. Opin. Neurobiol. 9 (1999) 349-354
74. Woolley C.S., and Schwartzkroin P.A. Hormonal effects on the brain. Epilepsia 39 (1998) S2-S8
75. Zahn C.A., Morrell M.J., Collins S.D., Labiner D.M., and Yerby M.S. Management issues for women with epilepsy: a review of the literature. Neurology 51 (1998) 949-956